Neutral
Azitra, Inc. Announces Q1 2026 Financial Results and Pipeline Milestones for Biotherapeutics and Cosmeceuticals
Azitra, Inc. (NYSEAMER: AZTR) announced its Q1 2026 financial results, reporting increased R&D expenses and a net loss of $3.93 million, but also a si...